BRNS
Price
$0.73
Change
-$0.00 (-0.00%)
Updated
Jan 16 closing price
Capitalization
29.61M
61 days until earnings call
Intraday BUY SELL Signals
SLNO
Price
$42.48
Change
+$0.53 (+1.26%)
Updated
Jan 16 closing price
Capitalization
2.28B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BRNS vs SLNO

Header iconBRNS vs SLNO Comparison
Open Charts BRNS vs SLNOBanner chart's image
Barinthus Biotherapeutics
Price$0.73
Change-$0.00 (-0.00%)
Volume$23.31K
Capitalization29.61M
Soleno Therapeutics
Price$42.48
Change+$0.53 (+1.26%)
Volume$1.17M
Capitalization2.28B
BRNS vs SLNO Comparison Chart in %
BRNS
Daily Signal:
Gain/Loss:
SLNO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BRNS vs. SLNO commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Hold and SLNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (BRNS: $0.73 vs. SLNO: $42.48)
Brand notoriety: BRNS and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 27% vs. SLNO: 74%
Market capitalization -- BRNS: $29.61M vs. SLNO: $2.28B
BRNS [@Biotechnology] is valued at $29.61M. SLNO’s [@Biotechnology] market capitalization is $2.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, BRNS is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 2 TA indicator(s) are bullish while SLNO’s TA Score has 4 bullish TA indicator(s).

  • BRNS’s TA Score: 2 bullish, 6 bearish.
  • SLNO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLNO is a better buy in the short-term than BRNS.

Price Growth

BRNS (@Biotechnology) experienced а -4.53% price change this week, while SLNO (@Biotechnology) price change was -1.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

BRNS is expected to report earnings on Mar 20, 2026.

SLNO is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($2.28B) has a higher market cap than BRNS($29.6M). BRNS YTD gains are higher at: 3.571 vs. SLNO (-8.251). BRNS (-69.65M) and SLNO (-72.08M) have comparable annual earnings (EBITDA) . SLNO has more cash in the bank: 499M vs. BRNS (74.3M). BRNS has less debt than SLNO: BRNS (11.6M) vs SLNO (52.7M). SLNO has higher revenues than BRNS: SLNO (98.7M) vs BRNS (0).
BRNSSLNOBRNS / SLNO
Capitalization29.6M2.28B1%
EBITDA-69.65M-72.08M97%
Gain YTD3.571-8.251-43%
P/E RatioN/AN/A-
Revenue098.7M-
Total Cash74.3M499M15%
Total Debt11.6M52.7M22%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRNSSLNO
RSI
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 16 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signal:
Gain/Loss:
SLNO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJSSX15.420.01
+0.06%
VY® JPMorgan Small Cap Core Equity S
GEGCX17.48N/A
N/A
abrdn Emerging Markets C
IGISX21.01-0.05
-0.24%
Voya Growth and Income Port S2
PAWAX75.29-0.25
-0.33%
T. Rowe Price All-Cap Opportunities-Adv
AHSAX23.30-0.14
-0.60%
Alger Health Sciences A

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-0.67%
SLNO - BRNS
56%
Loosely correlated
+1.26%
NGNE - BRNS
51%
Loosely correlated
-2.82%
NEUP - BRNS
50%
Loosely correlated
+0.24%
TARA - BRNS
35%
Loosely correlated
-0.60%
BGMS - BRNS
31%
Poorly correlated
+11.89%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+1.26%
BRNS - SLNO
56%
Loosely correlated
-0.67%
GRCE - SLNO
38%
Loosely correlated
+0.27%
BHVN - SLNO
36%
Loosely correlated
+10.23%
KROS - SLNO
35%
Loosely correlated
-2.08%
NKTX - SLNO
34%
Loosely correlated
+4.08%
More